✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Neogen Corp

Common Name
Neogen
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
2,974
Ticker
NEOG
Exchange
NASDAQ/NGS
Description
Neogen Corporation develops, manufactures, and markets products and services dedicated to food and animal safety worldwide. Operating through two primary segments, Food Safety and Animal Safety, the c...

Neogen's Financial Statements Preview

Below are the financial statements of Neogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2025 as of 2025-05-31
2024 as of 2024-05-31
Assets——
Current assets——
Cash and cash equivalents
129a
170.61a
Marketable securities
0a
0.33a
Accounts receivable, net
153.38a
173.01a
Inventory, net
190.86a
189.27a
Assets held for sale
50.4a
0a
Prepaid expenses and other current assets
53.29a
56.03a
Total current assets
576.94a
589.23a
Property and equipment——
Land and improvements
10.82a
10.5a
Building and improvements
108.72a
108.3a
Machinery and equipment
180.82a
176.37a
Furniture and fixtures
7.96a
8.26a
Construction in progress
186.24a
113.97a
Total property and equipment
494.56a
417.39a
Less accumulated depreciation
-155.43a
-140.29a
Property and equipment, net
339.13a
277.1a
Other assets——
Right of use assets
17.15a
14.79a
Goodwill
1,064.9a
2,135.63a
Amortizable intangible assets, net
1,410.49a
1,511.65a
Other non-current assets
35.23a
20.43a
Total other assets
2,527.77a
3,682.5a
Total assets
3,443.84a
4,548.83a
Liabilities and stockholders’ equity——
Current liabilities——
Current portion of debt
19.3a
2.45a
Accounts payable
79.61a
83.06a
Accrued compensation
14.13a
19.95a
Income tax payable
5.6a
10.45a
Accrued interest
11.08a
10.99a
Deferred revenue
5.56a
4.63a
Liabilities held for sale
6.56a
0a
Other current liabilities
32.18a
22.8a
Total current liabilities
174.01a
154.32a
Deferred income tax liability
280.91a
326.72a
Non-current debt
874.81a
888.39a
Other non-current liabilities
42.85a
35.26a
Total liabilities
1,372.58a
1,404.69a
Stockholders’ equity——
Preferred stock
0a
0a
Common stock
34.73a
34.66a
Additional paid-in capital
2,601.85a
2,583.89a
Accumulated other comprehensive loss
-28.9a
-30.02a
Retained earnings (accumulated deficit)
-536.42a
555.62a
Total stockholders’ equity
2,071.25a
3,144.14a
Total liabilities and stockholders’ equity
3,443.84a
4,548.83a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Neogen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Neogen's 10-K 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?